Services Support
Online inquiry

For Research Use Only. Not For Clinical Use.

Contact us
  • Email:

Teratoma Formation Assay Service

Introduction Teratoma Formation Assays Workflow What We Can Offer Customer Reviews FAQs Related Sections

Introduction

Creative Biolabs' Teratoma Formation Assay Service is the definitive functional test for iPSC pluripotency, validating multi-lineage differentiation that in vitro assays cannot replicate by proving response to systemic developmental signals and epigenetic remodeling. Leveraging advanced xenograft platforms, standardized histological analysis, and immunodeficient mouse models, we deliver quantitative data, expert pathological review, and gold-standard evidence for regulatory filings and high-impact publications.

Discover How We Can Help - Request a Consultation

Teratoma Formation Assays for iPSC

The teratoma formation assay, the gold standard functional test for iPSC pluripotency, is essential for iPSC research and application for three core reasons. It verifies functional pluripotency by confirming iPSCs' ability to differentiate into all three germ layers in vivo, a criterion that in vitro assays cannot fully reflect. It ensures safety by eliminating risky cell lines and provides a quality control basis for iPSC culture and modification to maintain cell quality stability.

Core Principles

When undifferentiated iPSCs are transplanted into immunodeficient mice (e.g., NOD/SCID mice), they form teratomas, benign tumors containing heterogeneous tissues derived from the three germ layers. The presence of these diverse tissues directly verifies the pluripotent potential of iPSCs.

Key Experimental Procedures

  • Cell Preparation: Harvest undifferentiated iPSC colonies, dissociate them into single cells or small cell clusters, and resuspend in a suitable matrix (e.g., Matrigel) to support in vivo survival and growth.
  • In Vivo Transplantation: Inject the cell-matrix mixture into immunodeficient mice, commonly via subcutaneous, intramuscular, or testicular injection routes for efficient teratoma formation.
  • Tumor Harvesting: After 4-8 weeks of incubation, euthanize the mice and harvest the formed teratomas when they reach an appropriate size.
  • Histological Analysis: Fix, embed, section, and stain the teratoma tissues (e.g., H&E staining). Microscopically identify tissue types representative of the three germ layers (e.g., neural tissues for ectoderm, cartilage for mesoderm, glandular structures for endoderm).

Critical Notes

  • Strictly use immunodeficient animal models to avoid immune rejection of transplanted iPSCs.
  • Ensure the iPSCs are in a stable undifferentiated state before transplantation to guarantee assay accuracy.
  • The assay requires compliance with relevant animal experiment ethics and regulations.

Workflow

To ensure the most accurate assessment of pluripotency, Creative Biolabs utilizes a rigorous, multi-step workflow optimized for reproducibility and sensitivity.

What We Can Offer

As an industry leader in regenerative medicine services, Creative Biolabs provides a comprehensive and fully customizable platform for Teratoma Formation Assay Service. We understand that every iPSC project has unique requirements, and we offer bespoke solutions that bridge the gap between bench-side research and clinical application.

Customized injection protocols

tailored to specific cell line growth characteristics and client-defined endpoints;

Strategic use of multiple validated immunodeficient mouse models

(NSG, Nude, SCID) to maximize engraftment success;

Precision surgical delivery

across various anatomical sites, including subcutaneous, intramuscular, and subcapsular injections;

Advanced co-injection matrices

and proprietary scaffold optimizations to enhance sensitivity for challenging cell lines;

Full-spectrum histopathological analysis

utilizing both standard H&E and specialized IHC markers for germ-layer identification;

Strict adherence to animal welfare and Quality-by-Design (QbD) principles

throughout the longitudinal in vivo study;

Detailed reporting and documentation

compliant with high-standard regulatory and peer-reviewed publication requirements.

Experience the Creative Biolabs Advantage - Get a Quote Today

Case Study

Teratoma formed by human embryonic stem cell lines (such as the H9 lineage) implanted in immunodeficient mice can be stained with hematoxylin-eosin, Wechsler staining, alizarin red, Masson tricolor staining, and Wegherter's staining, which can be used to evaluate cell pluripotency.

Teratoma was stained and analyzed using different staining methods. (OA Literature)Fig.1 Morphological detection of teratoma derived from human pluripotent stem cells.1

Customer Reviews

FAQs

Q: Why should I choose a teratoma assay over simpler in vitro tests?

A: While in vitro tests are faster, they only measure mRNA or surface markers. The teratoma assay is the only test that proves your cells can physically organize into complex tissues, which is a key requirement for therapeutic safety and efficacy.

Q: Which injection site is most recommended for iPSC validation?

A: The intramuscular or subcutaneous sites are most common for ease of monitoring. However, the kidney capsule is often used for higher sensitivity if the cell line shows poor growth characteristics in other sites.

Q: How do you ensure the animals do not reject the human cells?

A: We exclusively use highly immunodeficient strains like NSG or Nude mice, which lack T, B, and sometimes NK cell function, ensuring high engraftment rates for human iPSCs.

Q: Can this assay detect if my cells are malignant?

A: Yes. Beyond pluripotency, our pathologists specifically look for signs of teratocarcinoma or undifferentiated clusters, which can indicate genomic instability or incomplete differentiation.

Q: What is the typical number of mice used per cell line?

A: Standard protocols usually involve 3-5 mice per cell line to ensure statistical significance and to account for any biological variability in tumor growth.

Creative Biolabs offers a robust, end-to-end solution for Teratoma Formation Assay Service, providing the critical validation needed for both basic research and clinical translation. Our combination of surgical precision, high-grade animal models, and expert pathology ensures that your pluripotency data is beyond reproach.

Contact Our Team for More Information and to Discuss Your Project

Related Sections

Reference

  1. Smith, L. A., et al. "Using advanced cell culture techniques to differentiate pluripotent stem cells and recreate tissue structures representative of teratoma xenografts." Frontiers in Cell and Developmental Biology 9 (2021): 667246. https://doi.org/10.3389/fcell.2021.667246. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.